ArticleBMC cancer2020

Current status of the clinical use of PD-1/PD-L1 inhibitors: a questionnaire survey of oncologists in China.

Bicheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.